BR9611734A - Fas ligand fusion protein - Google Patents

Fas ligand fusion protein

Info

Publication number
BR9611734A
BR9611734A BR9611734A BR9611734A BR9611734A BR 9611734 A BR9611734 A BR 9611734A BR 9611734 A BR9611734 A BR 9611734A BR 9611734 A BR9611734 A BR 9611734A BR 9611734 A BR9611734 A BR 9611734A
Authority
BR
Brazil
Prior art keywords
fusion protein
fas ligand
ligand fusion
fas
protein
Prior art date
Application number
BR9611734A
Other languages
Portuguese (pt)
Inventor
Thomas Buehler
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR9611734A publication Critical patent/BR9611734A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9611734A 1995-11-16 1996-11-15 Fas ligand fusion protein BR9611734A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9523469.6A GB9523469D0 (en) 1995-11-16 1995-11-16 Organic compounds
PCT/EP1996/005039 WO1997018307A1 (en) 1995-11-16 1996-11-15 Fas ligand fusion protein

Publications (1)

Publication Number Publication Date
BR9611734A true BR9611734A (en) 1999-02-23

Family

ID=10784000

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9611734A BR9611734A (en) 1995-11-16 1996-11-15 Fas ligand fusion protein

Country Status (10)

Country Link
EP (1) EP0879285A1 (en)
JP (1) JP2000500336A (en)
CN (1) CN1202200A (en)
AU (1) AU7684896A (en)
BR (1) BR9611734A (en)
CA (1) CA2232876A1 (en)
CO (1) CO4520295A1 (en)
GB (1) GB9523469D0 (en)
WO (1) WO1997018307A1 (en)
ZA (1) ZA969623B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544523B1 (en) * 1996-11-13 2003-04-08 Chiron Corporation Mutant forms of Fas ligand and uses thereof
GB9705744D0 (en) * 1997-03-20 1997-05-07 Davies Alison M Methods for selecting cells and their uses
AU734758B2 (en) * 1997-04-01 2001-06-21 Sankyo Company Limited Anti-fas antibodies
US6972323B1 (en) 1997-04-01 2005-12-06 Sankyo Company, Limited Anti-Fas antibodies
US6451759B1 (en) * 1998-01-14 2002-09-17 The Regents Of The University Of California Noncleavable Fas ligand
AU2880400A (en) * 1999-02-12 2000-08-29 Amgen, Inc. Tnf-related proteins
GB9905503D0 (en) 1999-03-10 1999-05-05 Adprotech Plc Novel compound formulations and methods of delivery
CA2395945C (en) * 2000-01-03 2013-12-24 Tr Associates, L.L.C. Novel chimeric proteins and methods for using the same
US7927602B2 (en) 2002-07-23 2011-04-19 University Of Louisville Research Foundation, Inc. Fas ligand-avidin/streptavidin fusion proteins
WO2001052664A1 (en) * 2000-01-24 2001-07-26 University Of Louisville Research Foundation, Inc. Immune modulation with death receptor-induced apoptosis
CA2413237C (en) 2000-06-30 2013-09-10 University Of Louisville Research Foundation, Inc. Alteration of cell membrane for new functions
CA2812057A1 (en) 2010-09-28 2012-04-05 Kahr Medical Ltd. Compositions and methods for treatment of hematological malignancies
CN110662839A (en) * 2017-02-17 2020-01-07 珀杜研究基金会 Targeted ligand-payload based drug delivery for cell therapy
DK3592392T3 (en) * 2017-03-10 2023-10-23 Univ Louisville Res Found Inc FASL-MANIPULATED BIOMATERIALS WITH IMMUNOMODULATORY FUNCTION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6237145U (en) * 1985-08-23 1987-03-05
US5223408A (en) * 1991-07-11 1993-06-29 Genentech, Inc. Method for making variant secreted proteins with altered properties
JPH0590011A (en) * 1991-09-26 1993-04-09 Anritsu Corp Thermosensitive resistor and its manufacture
JPH05332845A (en) * 1992-06-03 1993-12-17 Kobe Steel Ltd Output conversion method and device of temperature detector
ATE387458T1 (en) * 1994-01-07 2008-03-15 Mochida Pharm Co Ltd FAS ANTIGEN BINDING LIGAND

Also Published As

Publication number Publication date
JP2000500336A (en) 2000-01-18
CA2232876A1 (en) 1997-05-22
CN1202200A (en) 1998-12-16
CO4520295A1 (en) 1997-10-15
AU7684896A (en) 1997-06-05
ZA969623B (en) 1998-05-15
GB9523469D0 (en) 1996-01-17
WO1997018307A1 (en) 1997-05-22
EP0879285A1 (en) 1998-11-25

Similar Documents

Publication Publication Date Title
DE59605502D1 (en) AREA ELEMENT
IS5375A (en) KAY-Innovative Immune Protein
DE69623712D1 (en) INTERFACE SYSTEM
DK0807198T3 (en) joint system
DE69839603D1 (en) ORNAMENTAL PROTEINS
GB9718609D0 (en) Fusion protein
DE69634279D1 (en) Interconnects
DE69621211D1 (en) joint arrangement
DE69602671D1 (en) Interconnects
BR9611734A (en) Fas ligand fusion protein
NO980566D0 (en) Allergen-XCD32 fusion proteins
NO976058L (en) Recombinant Mistakine
DE69826857D1 (en) OPHTHALMIC COMPOSITE LENS
BR9601670A (en) Tri-slide zipper
BR9609671A (en) Amino uracilas substituted
DE69601919D1 (en) PERCOLATOR
DE69621746D1 (en) Interconnects
BR9606756A (en) Peptide
ATA141195A (en) CONNECTING FITTING CONNECTING FITTING
TR199701666A3 (en) Proteins
NO981052D0 (en) peptide
FR2733287B1 (en) HOMOCINETIC JOINT
DE69625037D1 (en) SCRAP FUSION
DE69603897D1 (en) Interconnects
NO981051D0 (en) peptide

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law